Vinpocetine

Vinpocetine, a powerful cognitive enhancer presently in use in over 35 countries around the world. As clinical studies have shown, Vinpocetine helps maintain healthy circulation in the brain and accelerates cerebral metabolism. Vinpocetine also aids memory, increasing the concentration of certain neurotransmitters involved in memory formation, such as dopamine, noradrenaline, serotonine, and acetylcholine. By expanding the brain's blood vessels and optimizing the blood flow, Vinpocetine improves the brain's access to oxygen and other essential nutrients thus, maximizing mental performance.

Clinical trials have proven that Vinpocetine meaningfully improves the outcome of stroke patients, even when administered long after the initial stroke event. In a 1985 Japanese study, researchers demonstrated improvement in two-thirds of stroke patients receiving Vinpocetine.(12) Vinpocetine's effectiveness in stroke recovery is likely due in part to its remarkable ability to dilate brain arteries, enhancing brain blood flow in patients with cerebrovascular disease. This improves delivery of lifegiving oxygen to marginally functioning areas of the brain.

As a potent antioxidant and neuroprotector, Vinpocetine limits ongoing brain damage from free radical production.(13) In addition, it increases the flexibility of red blood cells and reduces the tendency of red blood cells and platelets to stick together, further enhancing blood flow to damaged areas of the brain while reducing the risk of subsequent stroke.(14,15)

Italian researchers have confirmed the effectiveness of Vinpocetine in treating vascular dementia. In a 1987 study published in the Journal of the American Geriatric Society, their report stated, "56 percent of the patients in the Vinpocetine group made good to excellent improvement since entering the study."(16)

Directions: Adults take 1 or 2 capsules daily or as directed by a health care professional.

References

1. Otomo, E., Ataractic, J., Arakai, G., et al., comparison of Vinpocetine with ifenprodil tartrate and dihydroergotoxine mesylate treatment and results of long-term treatment with Vinpocetine. Curr Therapeut Res, 37:811-821, 1985.
2. Tamaki, N., Kusunoki, T., Matsumoto, S., The effect of Vinpocetine on cerebral blood flow in patients with cerebrovascular disease. Ther Hung, 33:13-21, 1985.
3. Olah, V.A. Balla, G., Balla, H., et al., An in vitro study of the hydroxl scavenger effect of caiton. Acta Paediatr Hung, 30: 309-316, 1990.
4. Osawa, M., Maruyama, S., Effects of TCV-3B (Vinpocetine) on blood viscosity in ischemic cerebrovascular disease. Ther Hung, 33: 7-12, 1985.
5. Hayakawa, M., Comparative efficacy of Vinpocetine, pentoxyifylline and nicergoline on red blood cell deformability. Arzneinmittelforschung, 42: 108-110, 1992.

Directions: Adults take 1 or 2 capsules daily or as directed by a health care professional.

Other Ingredients: Hypromellose (derved from cellulose and contains no animale byproducts)capsule. May contains one or more of the following hypoallergenic ingredients to fill space:Magnesium citrate, leucine, Silicon Dioxide

WARNING:Consult with your health care professional before taking this product. Do NOT take if you have low blood pressure or are taking a blood thinner.
Keep out of reach of children.

TAMPER EVIDENT: Use only if bottle is sealed.
Store tightly sealed in a cool dry place.